Short-term clinical outcomes of open, laparoscopic, and robotic-assisted rectal resections: a multicenter real-world evidence study from Indian collaborative group on rectal resections (ICGRR)
- PMID: 40380031
- PMCID: PMC12084228
- DOI: 10.1007/s11701-025-02375-5
Short-term clinical outcomes of open, laparoscopic, and robotic-assisted rectal resections: a multicenter real-world evidence study from Indian collaborative group on rectal resections (ICGRR)
Abstract
This multi-centric real-world study was carried out to assess the perioperative and histopathological clinical outcomes of rectal resections employing open, laparoscopic, and robotic-assisted techniques. A retrospective chart review was undertaken for patients who underwent rectal resections for Stages I, II, and III rectal cancer (RC) between April 2012 and August 2023. All surgical procedures were performed with the principles of total mesorectal excision (TME) or partial mesorectal excision (for tumors located higher in the rectum). The study analyzed data from 829 patients of which 314 were in the robotic-assisted group (RAS), 206 in the laparoscopic surgery group (LG), and 309 in the open-surgery group (OG). The TNM staging and location of RC were evenly distributed across the three groups. The RAS group had a significantly lower length of hospital stay than LG and OG. Compared to LG and OG, the RAS group had less blood loss and postoperative complications, but significantly longer mean operating room time. The conversion rate of the RAS group was significantly lower than that of the LG group (p = 0.03). In comparison to the OG and LG groups, the RAS group had significantly lower (p < 0.05) rates of positive circumferential resection margin (CRM). Adjuvant treatment was administered in the RAS group significantly earlier (median, 24.5 days, IQR 18-37) compared to the LG (median, 31 days, IQR 23-41) and OG (median, 32.5 days, IQR 27-42). This largest multi‑centric study by the ICRR group has validated the value of a relatively newer technology like RAS in real-world Indian settings for rectal resections.
Keywords: Abdominoperineal resection; Laparoscopic group; Low anterior resection; Open group; Rectal resections; Robotic-assisted surgery.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: AD and KB are employees of Intuitive Surgical, California, US. The other authors declare that they have no conflicts of interest concerning the publication of this work. The study was conducted independently, and the authors have no connections to, affiliations with, or financial relationships to any organizations that could unduly prejudice the content of this work. Ethics approval: The institutional ethics committee (IEC) or institutional review board (IRB) of each participating center granted permission for the study. The study was registered at the Clinical Trials Registry of India website with registration number CTRI/2023/03/050448. Consent to participate: Since this was a retrospective study that involved the collection of de-identified data without any direct participant interaction, the IRB/IEC waived the requirement for informed consent. Every study procedure conforms to the ethical norms of the participating institutions as well as the Declaration of Helsinki. Consent to publish: The corresponding author gives consent for this work to be published on behalf of all the authors. Financial interests: There are no financial interests of the authors that ought to be disclosed.
Similar articles
-
Robotic versus laparoscopic rectal resection for sphincter-saving surgery: pathological and short-term outcomes in a single-center analysis of 130 consecutive patients.Surg Endosc. 2017 Oct;31(10):4085-4091. doi: 10.1007/s00464-017-5455-7. Epub 2017 Mar 7. Surg Endosc. 2017. PMID: 28271268
-
Association of Surgical Approaches and Outcomes in Total Mesorectal Excision and Margin Status for Rectal Cancer.J Surg Res. 2024 Aug;300:494-502. doi: 10.1016/j.jss.2024.05.032. Epub 2024 Jun 14. J Surg Res. 2024. PMID: 38875948
-
Robotic versus laparoscopic surgery for middle and low rectal cancer (REAL): short-term outcomes of a multicentre randomised controlled trial.Lancet Gastroenterol Hepatol. 2022 Nov;7(11):991-1004. doi: 10.1016/S2468-1253(22)00248-5. Epub 2022 Sep 8. Lancet Gastroenterol Hepatol. 2022. PMID: 36087608 Clinical Trial.
-
Outcomes of open vs laparoscopic vs robotic vs transanal total mesorectal excision (TME) for rectal cancer: a network meta-analysis.Tech Coloproctol. 2023 May;27(5):345-360. doi: 10.1007/s10151-022-02739-1. Epub 2022 Dec 12. Tech Coloproctol. 2023. PMID: 36508067 Review.
-
Robotic-assisted versus laparoscopic-assisted extended mesorectal excision: a comprehensive meta-analysis and systematic review of perioperative and long-term outcomes.Surg Endosc. 2024 Nov;38(11):6464-6475. doi: 10.1007/s00464-024-11222-x. Epub 2024 Sep 13. Surg Endosc. 2024. PMID: 39269481
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. 10.3322/caac.21660. (Epub 2021 Feb 4) - PubMed
-
- Asthana S, Khenchi R, Labani S (2021) Incidence of colorectal cancers in India: a review from population-based cancer registries. Curr Med Res and Pract 11(2):91–96. 10.4103/cmrp.cmrp_65_20
-
- NCCN Guidelines (2024), Rectal cancer, version 3.0. https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf. Accessed 01 October 2024
-
- Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB (2019) Colorectal cancer. Lancet 394(10207):1467–1480. 10.1016/S0140-6736(19)32319-0 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous